資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/31715
|
| 標題: | Long-Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events |
| 作者: | Chang, Wei-Ting
Chang, Chia-Li
Ho, Chung-Han
Hong, Chon-Seng
Wang, Jhi-Joung
Chen, Zhih-Cherng |
| 貢獻者: | Chi Mei Med Ctr, Dept Cardiol
Chi Mei Med Ctr, Dept Med Res
Southern Taiwan Univ Sci & Technol, Dept Biotechnol
Chia Nan Univ Pharm & Sci, Dept Healthcare Adm
Chia Nan Univ Pharm & Sci, Dept Med Informat
Chia Nan Univ Pharm & Sci, Dept Pharm |
| 關鍵字: | cardiovascular events
mortality
thrombosis |
| 日期: | 2017-05 |
| 上傳時間: | 2018-11-30 15:53:59 (UTC+8) |
| 出版者: | Wiley |
| 摘要: | Background-Patients with unprovoked venous thromboembolism (VTE) are at an increased risk of mortality, but whether their cardiovascular risks also increase remains to be determined. We aimed to investigate the factors associated with overall mortality and major adverse cardiovascular events in patients with unprovoked VTE. Methods and Results-We identified 2154 patients newly diagnosed with unprovoked VTE from Taiwan's National Health Insurance Database between 2000 and 2013, excluding those with reversible etiologies, underlying cancer, or autoimmune diseases. These patients with VTE were compared with an age-, sex-, and cardiovascular risk-matched cohort of 4308 controls. The risk of mortality and major adverse cardiovascular events in patients with VTE was 2.23 (CI, 1.93-2.57; P<0.0001) and 1.86 (CI, 1.65-2.09; P<0.0001) times, respectively, higher than that of the conditions in controls. These events mostly occurred during the first year after the diagnosis of unprovoked VTE. Among patients with VTE, advanced age, male sex, and comorbid diabetes mellitus indicated a higher incidence of mortality and major adverse cardiovascular events. Conversely, comorbid hyperlipidemia attenuated these risks. Conclusions-This nation-wide cohort study revealed that patients with unprovoked VTE, particularly older males with diabetes mellitus, had an elevated risk of both mortality and cardiovascular events. Risk of mortality and major adverse cardiovascular events were highest within the first year after diagnosis and persisted during the 10 years of follow-up. |
| 關聯: | Journal of The American Heart Association, v.6, n.5, pp.e005466 |
| 顯示於類別: | [藥學系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 10.1161-JAHA.117.005466.pdf | | 275Kb | Adobe PDF | 0 | 檢視/開啟 | | index.html | | 0Kb | HTML | 1321 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
